News
Steps towards secure & inclusive digitalisation 03-09-2021
A set of EU digital principles: social security & health insurers’ views
As a follow-up to the Digital Compass Communication of 9 March, the Commission launched a public consultation on the formulation of a set of EU digital principles. These principles would be integrated in a joint declaration of the main EU institutions. ESIP and its Members are committed to and involved in the digitalisation of social security and healthcare systems, with a view to increasing their sustainability and accessibility within and across borders.
Proposals to improve EU rules on rare and paediatric diseases 30-07-2021
ESIP responds to the Public Consultation on the Revision of the OMP and paediatrics Regulations
As part of the legislative initiatives under the Pharmaceutical Strategy for Europe, the Commission opened consultations towards the revision of the EU legislation on medicines for children and rare diseases. ESIP provided its feedback building on the 2019 paper on orphan medicinal products and the previous response to the inception impact assessment.
Promoting access to health data for healthcare, research & policy-making 26-07-2021
ESIP responds to the Public Consultation on the upcoming European Health Data Space
In view of the legislative proposal for a European Health Data Space (EHDS), expected by the end of this year, ESIP took part in the public consultation process on access to and exchange of health data for healthcare provision, policy-making and research & innovation purposes, as well as on the use of digital health products & services and development & deployment of AI systems applied to healthcare.
How to better address cancer comorbidities & complications 12-07-2021
ESIP reflection paper on new approaches for health insurers
On 12 July, ESIP adopted its reflection paper on Cancer comorbidities and complications: proposals for a new approach for health insurers. The paper was prepared in the wake of the EU’s Beating Cancer Plan, published on 3 February, and as a follow up to the POLITICO Working Group on Cancer Comorbidities that ESIP joined on 24 February.
